Molecular Templates, Inc. (NASDAQ:MTEM) Sees Significant Growth in Short Interest

Molecular Templates, Inc. (NASDAQ:MTEM) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 2,460,000 shares, a growth of 810.8% from the October 31st total of 270,100 shares. Approximately 45.2% of the company’s shares are short sold. Based on an average daily volume of 10,020,000 shares, the short-interest ratio is presently 0.2 days.

Molecular Templates Price Performance

MTEM stock remained flat at $0.37 during trading on Thursday. The company’s stock had a trading volume of 2,548,851 shares, compared to its average volume of 2,901,174. The firm has a market cap of $2.46 million, a P/E ratio of -0.14 and a beta of 1.22. The company has a 50-day moving average price of $0.78 and a two-hundred day moving average price of $1.15. Molecular Templates has a 1-year low of $0.30 and a 1-year high of $5.37.

Insider Buying and Selling at Molecular Templates

In other Molecular Templates news, major shareholder Target N. V. Biotech sold 1,279,820 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $0.66, for a total transaction of $844,681.20. The sale was disclosed in a filing with the SEC, which is available through this link. 13.90% of the stock is currently owned by corporate insiders.

About Molecular Templates

Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).